Biotechnology News

![mylan july08][1]

Generic and specialty pharma company Mylan N.V. said its U.S.-based business Mylan Institutional LLC recalled one lot of bacterial infection antibiotic Daptomycin in the form of injection for the potential presence of particulate matter, according to the U.S. Food and Drug Administration or FDA.

![lupinpharma july08][2]

India-based Lupin Pharmaceuticals Inc. announced a recall of all batches of type 2 diabetes medication Metformin Hydrochloride Extended-Release Tablets, citing detection of N-Nitrosodimethylamine or NDMA, a probable human carcinogen. The move comes after many other drug companies called back Metformin tablets after the U.S. Food and Drug Administration or FDA recommended over NDMA concerns.

![fda recall 070720][3]

Granules Pharmaceuticals, Inc. recalled twelve (12) lots of type 2 diabetes medication Metformin hydrochloride Extended-Release, in the form of oral film-coated tablets, for the potential presence of nitrosamine impurity, N-Nitrosodimethylamine (NDMA), above levels of the Acceptable Daily Intake Limit (ADI), the U.S. Food and Drug Administration or FDA said in a statement.

![listeriaconcerns july01][4]

Garland Ventures Ltd is recalling Five Cheese Stuffed Shells citing possible presence of Listeria monocytogenes, the U.S. Food and Drug Administration said in a statement. The recall involves 1095 cases of Five Cheese Stuffed Shells trays that was distributed across the nation in limited number of retail stores.

  1. cdn.rttnews.com/articleimages/ustopstories/2020/july/mylan-july08.jpg (mylan july08)
  2. cdn.rttnews.com/articleimages/ustopstories/2020/july/lupinpharma-july08.jpg (lupinpharma july08)
  3. cdn.rttnews.com/articleimages/ustopstories/2020/july/fda-recall-070720.jpg (fda recall 070720)
  4. cdn.rttnews.com/articleimages/ustopstories/2020/july/listeriaconcerns-july01.jpg (listeriaconcerns july01)